Renascience Inc. (TYO:4889)
Japan flag Japan · Delayed Price · Currency is JPY
1,533.00
+37.00 (2.47%)
Jun 2, 2025, 3:30 PM JST

Renascience Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
Revenue
132194100139209
Upgrade
Revenue Growth (YoY)
-31.96%94.00%-28.06%-33.49%190.28%
Upgrade
Cost of Revenue
429-5929
Upgrade
Gross Profit
12816510080180
Upgrade
Selling, General & Admin
307167185193265
Upgrade
Research & Development
-23623582-
Upgrade
Other Operating Expenses
-131313-
Upgrade
Operating Expenses
307417434291265
Upgrade
Operating Income
-179-252-334-211-85
Upgrade
Interest Expense
----5-7
Upgrade
Currency Exchange Gain (Loss)
-1---1
Upgrade
Other Non Operating Income (Expenses)
1-1--26-
Upgrade
EBT Excluding Unusual Items
-179-253-334-242-91
Upgrade
Asset Writedown
-1-4--11-
Upgrade
Other Unusual Items
323----9
Upgrade
Pretax Income
143-257-334-253-100
Upgrade
Income Tax Expense
30111-
Upgrade
Net Income
113-258-335-254-100
Upgrade
Net Income to Common
113-258-335-254-100
Upgrade
Shares Outstanding (Basic)
1313131110
Upgrade
Shares Outstanding (Diluted)
1313131110
Upgrade
Shares Change (YoY)
--11.61%15.99%0.00%
Upgrade
EPS (Basic)
8.89-20.30-26.35-22.30-10.18
Upgrade
EPS (Diluted)
8.89-20.30-26.35-22.30-10.18
Upgrade
Free Cash Flow
-176-231-286-231-
Upgrade
Free Cash Flow Per Share
-13.85-18.17-22.50-20.28-
Upgrade
Gross Margin
96.97%85.05%100.00%57.55%86.12%
Upgrade
Operating Margin
-135.61%-129.90%-334.00%-151.80%-40.67%
Upgrade
Profit Margin
85.61%-132.99%-335.00%-182.73%-47.85%
Upgrade
Free Cash Flow Margin
-133.33%-119.07%-286.00%-166.19%-
Upgrade
EBITDA
-178-251-333-208-
Upgrade
EBITDA Margin
-134.85%-129.38%--149.64%-
Upgrade
D&A For EBITDA
1113-
Upgrade
EBIT
-179-252-334-211-85
Upgrade
EBIT Margin
-135.61%-129.90%--151.80%-40.67%
Upgrade
Effective Tax Rate
20.98%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.